Heron Therapeutics
(HRTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-1998 | 12-1997 | 09-1997 | 06-1997 | 03-1997 | |
| Sales | 4,572 | 4,649 | 4,137 | 4,500 | 5,047 |
| Cost of Goods | 1,750 | N/A | 1,757 | 1,952 | 1,492 |
| Gross Profit | 2,820 | 4,649 | 1,377 | 2,094 | 964 |
| Operating Expenses | 3,380 | 0 | 757 | 952 | 492 |
| Operating Income | 192 | 4,649 | 2,380 | 2,548 | 3,556 |
| Interest Expense | 220 | 0 | 261 | 269 | 271 |
| Other Income | 48 | 0 | -2,515 | -2,911 | -2,865 |
| Pre-tax Income | 20 | 4,649 | -395 | -632 | 419 |
| Net Income Continuous | 27 | -75 | -395 | -632 | 419 |
| Net Income | $27 | $-75 | $-395 | $-632 | $419 |
| EPS Basic Total Ops | 0.00 | 0.00 | -1.60 | -2.40 | 1.60 |
| EPS Basic Continuous Ops | 0.10 | -0.35 | -1.67 | -2.40 | 1.60 |
| EPS Diluted Total Ops | 0.00 | 0.00 | -1.60 | -2.40 | 1.60 |
| EPS Diluted Continuous Ops | 0.10 | -0.35 | -1.67 | -2.40 | 1.60 |
| EBITDA(a) | $522 | $4,649 | $2,380 | $2,548 | $3,556 |